Allison Tate Pastine, LCPC | |
7401 Ritchie Hwy, Glen Burnie, MD 21061-3101 | |
(443) 250-6653 | |
(410) 740-8068 |
Full Name | Allison Tate Pastine |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 7401 Ritchie Hwy, Glen Burnie, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023550746 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | LC3061 (Maryland) | Secondary |
101YP2500X | Counselor - Professional | LC3061 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Allison Tate Pastine, LCPC 642 Thomas Way, Severna Park, MD 21146-2832 Ph: (443) 250-6653 | Allison Tate Pastine, LCPC 7401 Ritchie Hwy, Glen Burnie, MD 21061-3101 Ph: (443) 250-6653 |
News Archive
Results from a 10-year study of children and adolescents who underwent a common weight loss operation to treat severe obesity show they safely have long-lasting major weight loss and improvement of their obesity-related medical problems without stunting their growth in height. The study, involving the longest known follow-up of pediatric patients after laparoscopic sleeve gastrectomy, is published online by the Journal of the American College of Surgeons ahead of print.
Like finally seeing all the gears of a watch and how they work together, researchers from UCLA and UC Berkeley have, for the first time ever, solved the puzzle of how the various components of an entire telomerase enzyme complex fit together and function in a three-dimensional structure.
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of end-stage age-related macular degeneration (AMD), today announced the closing of expansion of the Series E financing, with Agate Medical Investments leading the expansion round. Agate's Managing General Partner, Chanan Schneider, will join the VisionCare team as a board observer.
› Verified 5 days ago
Ms. Leslie A Stanbury, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Road North, Suite B, Glen Burnie, MD 21060 Phone: 410-222-0100 Fax: 410-222-0116 | |
Mr. Norman Wayne Smith Sr., LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 309 Kahler Way, Glen Burnie, MD 21060 Phone: 240-380-9957 | |
Sharon Clements, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1410 Crain Hwy N, Glen Burnie, MD 21061 Phone: 443-768-7235 | |
Tracey Letourneau, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 114 Alview Ter, Glen Burnie, MD 21060 Phone: 443-591-6418 | |
Ms. Traci A. Olivier, CSC-AD Counselor Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Road North, Suite B, Glen Burnie, MD 21060 Phone: 410-222-0100 Fax: 410-222-0116 | |
Tiffany Nicole Huff, ADT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1401 Madison Park Dr, Glen Burnie, MD 21061 Phone: 410-999-0891 |